Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

Behavioural Brain Research

Volumn 198, Issue 1, 2009, Pages 258-262

  Dean, Olivia ^a   Bush, Ashley I ^a   Berk, Michael ^b,c   Copolov, David L ^d   van den Buuse, Maarten ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

2 Cyclohexene 1 one; Animal model; Bipolar disorder; Cognition; Glutathione; Oxidative stress; Schizophrenia; Y maze

Indexed keywords

2 CYCLOHEXENONE; GLUTATHIONE;

ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SHORT TERM MEMORY; SPATIAL MEMORY; STRIATE CORTEX;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; COGNITION; CORPUS STRIATUM; CYCLOHEXENES; EXPLORATORY BEHAVIOR; FRONTAL LOBE; GLUTATHIONE; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; SPATIAL BEHAVIOR;

EID: 58549098713     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.11.017     Document Type: Article

References (42)

1. Ng F., Berk M., Dean O., and Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11 6 (2008) 851-876
2. Do K.Q., Trabensinger M.K., Lauer C.J., Dydak U., Hell D., Holsboer F., et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12 (2000) 3721-3728
3. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111 2-3 (2008) 135-144
4. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79 3 (2006) 586-592
5. Do K.Q., Lauer C.J., Schreiber W., Zollinger M., Gutteck-Amsler U., Cuenod M., et al. gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem 65 6 (1995) 2652-2662
6. Altschule M.D., and Giancola J.N. Effect of injections of placebos on blood glutathione level and eosinophil counts in chronic schizophrenia. Compr Psychiatry 1 (1960) 250-252
7. Yao J.K., Leonard S., and Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers 22 1-2 (2006) 83-93
8. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-Acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol Psychiatry 64 6 (2008) 469-475
9. Berk M., Copolov D., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-Acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64 5 (2008) 361-368
10. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31 5 (2006) 699-703
11. Valvassori S.S., Petronilho F.C., Reus G.Z., Steckert A.V., Oliveira V.B., Boeck C.R., et al. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 32 4 (2008) 1064-1068
12. Masukawa T., Sai M., and Tochino Y. Methods for depleting brain glutathione. Life Sci 44 6 (1989) 417-424
13. Reliene R., and Schiestl R.H. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. Carcinogenesis 27 2 (2006) 240-244
14. Watanabe T., Sagisaka H., Arakawa S., Shibaya Y., Watanabe M., Igarashi I., et al. A novel model of continuous depletion of glutathione in mice treated with l-buthionine (S, R)-sulfoximine. J Toxicol Sci 28 5 (2003) 455-469
15. Cruz-Aguado R., Almaguer-Melian W., Diaz C.M., Lorigados L., and Bergado J. Behavioural and biochemical effects of glutathione depletion in the rat brain. Brain Res Bul 55 3 (2001) 327-333
16. Hill K.E., Von Hoff D.D., and Burk R.F. Effect of inhibition of gamma-glutamyltanspeptidase by AT-125 (Acivicin) on glutathione and cysteine levels in rat brain and plasma. Invest New Drug 3 (1985) 31-34
17. Pileblad E., and Magnusson T. Intracerebronventricular administration of l-buthionine sulfoximine: a method for depleting brain glutathione. J Neurochem 53 (1989) 1878-1882
18. Castagne V., Rougemont M., Cuenod M., and Do K.Q. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia. Neurobiol Dis 15 1 (2004) 93-105
19. Hall N.C., Carney J.M., Plante O.J., Cheng M., and Butterfield D.A. Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids. Neuroscience 77 1 (1997) 283-290
20. Wedner H.J., Simchowitz L., Stenson W.F., and Fischman C.M. Inhibition of human polymorphonuclear leukocyte function by 2-cyclohexene-1-one. A role for glutathione in cell activation. J Clin Invest 68 2 (1981) 535-543
21. Piskulic D., Olver J.S., Norman T.R., and Maruff P. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res 150 2 (2007) 111-121
22. Malhi G.S., Ivanovski B., Hadzi-Pavlovic D., Mitchell P.B., Vieta E., and Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 9 1-2 (2007) 114-125
23. Robinson L.J., and Ferrier I.N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8 2 (2006) 103-116
24. Kamboj A., Kiran R., and Sandhir R. Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine. Exp Brain Res 170 4 (2006) 567-575
25. Castagne V., Cuenod M., and Do K.Q. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development. Neuroscience 123 4 (2004) 821-834
26. Dellu F., Contarino A., Simon H., Koob G.F., and Gold L.H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 73 1 (2000) 31-48
27. Benzi G., Curti D., Marzatico F., and Pastoris O. Age-related acute depletion of cerebral glutathione by peroxidative stress. J Neurosci Res 29 (1991) 527-532
28. Baker M.A., Cerniglia G.J., and Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190 2 (1990) 360-365
29. Dellu F., Mayo W., Cherkaoui J., Le Moal M., and Simon H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res 588 1 (1992) 132-139
30. Adams W., Kusljic S., and van den Buuse M. Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology 55 6 (2008) 1048-1055
31. Wang J.H., Ma Y.Y., and van den Buuse M. Improved spatial recognition memory in mice lacking adenosine A2A receptors. Exp Neurol 199 2 (2006) 438-445
32. Agarwal R., and Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 24 12 (1999) 1507-1514
33. Pileblad E., and Magnusson T. Effective depletion of glutathione in rat striatum and substantia nigra by l-buthionine sulfoximine in combination with 2-cylcohexene-1-one. Life Sci 47 (1990) 2333-2342
34. Dellu F., Fauchey V., Le Moal M., and Simon H. Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol Learn Mem 67 2 (1997) 112-120
35. Yao J.K., Reddy R.D., and van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15 4 (2001) 287-310
36. Rabinovic A.D., Lewis D.A., and Hastings T.G. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101 1 (2000) 67-76
37. Sonsalla P.K. The role of N-methyl-d-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. Drug Alcohol Depend 37 2 (1995) 101-105
38. Mahadik S.P., and Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19 (1996) 1-17
39. Oja S.S., Janaky R., Varga V., and Saransaari P. Modulation of glutamate receptor functions by glutathione. Neurochem Int 37 2-3 (2000) 299-306
40. Janaky R., Varga V., Oja S.S., and Saransaari P. Release of [3H]GABA evoked by glutamate agonists from hippocampal slices: effects of dithiothreitol and glutathione. Neurochem Int 24 6 (1994) 575-582
41. Prediger R.D., Franco J.L., Pandolfo P., Medeiros R., Duarte F.S., Di Giunta G., et al. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: evidence for a dissociation between cognitive deficits and the glutathione system response. Behav Brain Res 177 2 (2007) 205-213
42. Cabungcal J.H., Preissmann D., Delseth C., Cuenod M., Do K.Q., and Schenk F. Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: relevance to schizophrenia. Neurobiol Dis 26 3 (2007) 634-645